Figure 3.
Human SAA1, 2 mRNA levels in Nephromine data sets from humans with DKD. (a) Woroniecka study of glomerular samples: DKD (diabetic nephropathy) samples vs healthy living donor controls, P=0.017 (control n=13, DKD n=9). (b) Schmid study of tubulointerstitial compartment: DKD (diabetic nephropathy) samples vs controls, P=0.021 (n=11 for controls, n=11 for DKD). Data are displayed as median and interquartile range with 95% confidence intervals for log2-transformed data. DKD, diabetic kidney disease; SAA, serum amyloid A.